Oral Rinse Could Provide Early Screening for Gastric Cancer
A simple oral rinse may lead to early detection of gastric cancer, according to new findings presented at Digestive Disease Week (DDW) 2024.
A simple oral rinse may lead to early detection of gastric cancer, according to new findings presented at Digestive Disease Week (DDW) 2024.
This symposium, led by Ozlem Goker-Alpan, MD of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) reviews the current state of newborn screening…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
The FDA has updated the PDUFA target action date for the BLA for subcutaneous nivolumab in advanced or metastatic solid tumors.
The FDA has granted orphan drug designation to azeliragon as a potential therapeutic option for patients with pancreatic cancer.
Routine cognitive testing may help older drivers plan for life after driving
Inavolisib/palbociclib/fulvestrant was granted FDA granted breakthrough therapy designation for PIK3CA-mutated, HR-positive/HER2-negative breast cancer.
S. Vincent Rajkumar, MD, discusses highly anticipated abstracts in multiple myeloma that will be presented at the 2024 ASCO Annual Meeting.
Yi-Bin Chen leads the panel in a review of various GVHD prophylaxis regimens.
Douglas W. Sborov, MD, MS, presents the case of a 54-year-old woman with newly diagnosed multiple myeloma.
Ashwin Kishtagari, MD, discusses the investigation of JAK inhibitor–based combinations in myelofibrosis.